09.03.2017 • News

Sven Schneider Named CFO of Linde

(c) Linde AG
(c) Linde AG

Sven Schneider has been named to the managing board of German industrial gases and engineering group Linde with the function of chief financial officer. The 50-year-old German has assumed the CFO’s role on an interim basis since September 2016. His predecessor, Georg Denoke, was forced to step down after siding with labor representatives on the supervisory board against the company’s plans to merge with US rival Praxair.

Prior to taking on the CFO role, Schneider was head of Group Treasury at Linde from April 2011. Previous positions included head of Corporate Finance and head of Cash Management / Treasury Controlling.

Along with appointing Schneider, the supervisory board has extended the contracts of managing board members Bernd Eulitz and Christian Bruch by five years each.

Meanwhile, reports say Dublin, Ireland, is the front runner to become official headquarters of the holding of the new Linde, which will incorporate the German group’s gases division and Praxair. The engineering division will remain in Munich. Previous speculation had focused on Amsterdam or London as holding headquarters. The new player, to be headed by Praxair’s Steve Angel as CEO, will be managed from the US, however.

The split corporate functions, common among pharmaceutical companies settling in Ireland for tax reasons, are somewhat more unusual among chemical producers – LyondellBasell practices this model, with a holding headquartered in the Netherlands and management based in the US.

Linde’s workforce and a number of shareholders are said to still be unhappy with the merger plans.  While employees fear the loss of co-determination rights with the new entity steered from the US, shareholders say they have not been informed about the fusion plans in sufficient detail.

Linde is due to present annual results on Mar. 9.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.